Patent · US Active

Stilbene derivatives for the treatment of CNS and other disorders

US11286233B2 · kind B2 · utility

2Cited by
3References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 8, 2018
Grant dateMar 29, 2022
Priority date
Expiry dateJun 28, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D215/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application discloses stilbene derivative compounds and compositions, and methods for treating ocular diseases, neurological disorders and protein aggregation-related disorders in patients using the compounds and compositions as disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.